Trial
NCT03402789
Docosahexaenoic Acid (DHA) Supplementation in Amblyopia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Amblyopia
Intervention
Docosahexaenoic Acid
Why stopped
Hopkins failed to review contract with company providing complimentary dha, support was withdrawn necessitating me to get more grant money to fund study which was unsucccessful.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-09